Unknown OBSERVATIONAL NCT05237037

Assessment of Sleep Quality in Cannabinoid Therapy

Assessment of Sleep Quality in Patients Utilizing Cannabinoid Therapy

Sponsor: Cerebra Medical

Updated 7 times since 2022 Last updated: Feb 6, 2023 Started: Aug 22, 2022 Primary completion: Aug 31, 2023 Completion: Aug 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Poor Sleep Quality and is currently ongoing. Cerebra Medical leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting
Sep 2022 — Mar 2023 [monthly]

Recruiting

▶ Show 2 earlier versions

Jun 2022 — Sep 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Mar 2022 — Jun 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cerebra Medical
Ekosi Health Centre

Data source: Cerebra Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winnipeg, Canada